ArticleFrontiers in immunology2026
Inflammation-associated brain functional network topological disruption in female nurses with SWSD: associations with symptoms and transcriptomics.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Shift work sleep disorder (SWSD) is prevalent among female nurses and is associated with significant health morbidities. While inflammation is implicated in SWSD, how it relates to brain network alterations and clinical symptoms remains underexplored. This study aimed to investigate the associations among peripheral inflammation, brain functional network topological disruptions, clinical symptoms, and transcriptomic signatures in female nurses with SWSD. Methods: Fifty female nurses with SWSD and 50 healthy daytime-working controls (HCs) comparable in age and education underwent clinical assessments, quantification of peripheral inflammatory markers, and resting-state functional magnetic resonance imaging (rs-fMRI). Graph theory was applied to rs-fMRI data to assess brain network topology. Mediation analyses were used to evaluate the pathways linking inflammation, network topology, and symptoms. Imaging transcriptomics, leveraging the Allen Human Brain Atlas, was used to identify gene expression patterns correlated with network alterations. Machine learning models were employed to assess the utility of these multimodal features in classifying SWSD. Results: Compared with HCs, nurses with SWSD exhibited immune dysregulation (elevated levels of interferon α (IFN-α), IFN-γ, interleukin 4 (IL-4), IL-5, IL-17A, and particularly IL-6). Graph analysis revealed altered global network topology (reduced global efficiency and small-worldness, increased local efficiency, clustering coefficient, and characteristic path length) alongside significant nodal changes, notably increased local efficiency and clustering coefficient in the left medial superior frontal gyrus (SFGmed.L). These topological alterations were significantly correlated with the severity of clinical symptoms. Mediation analyses indicated that global small-worldness mediated the relationship between IL-6 levels and poor sleep quality, whereas the local efficiency of SFGmed.L mediated the associations between IFN-γ levels and anxiety and cognitive performance. The support vector classifier model accurately differentiated nurses with SWSD from HCs (accuracy: 90%). Imaging transcriptomics identified spatial gene-expression patterns associated with altered nodal topology, particularly involving genes related to cytokine signaling and cellular regulation. Discussion: Our findings suggest that systemic inflammation is associated with characteristic brain functional network disruptions in female nurses with SWSD, and that these disruptions are associated with clinical symptoms. These inflammation-related neurobiological alterations, together with spatially associated transcriptomic signatures, provide novel insights into SWSD pathophysiology and may help identify potential biomarkers and therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.